期刊文献+

两种体位激发试验对醛固酮瘤的诊断价值 被引量:1

Comparison of the clinical values of two different posture tests for diagnosis of aldosterone producing adenoma
下载PDF
导出
摘要 目的:比较单纯体位激发试验及体位联合呋塞米双重激发试验对临床确诊的醛固酮瘤(APA)患者肾素活性(PRA)、醛固酮(ALD)、醛固酮/肾素比值(ARR)的影响。方法:对112例经我院手术切除并行病理检查确诊为醛固酮瘤(APA)的患者进行统计分析,其中60例术前行单纯体位激发试验(单纯激发组),52例行体位联合呋塞米双重激发试验(双重激发组),比较两组患者的一般情况、PRA、ALD数值,并计算ARR。结果:行体位联合呋塞米双重激发试验与单纯体位激发试验患者的一般情况、PRA、ALD、ARR均无显著性差异,双重激发组不良反应更多见,与单纯体位激发组相比差异有统计学意义(P<0.05)。结论:在体位激发试验中是否加用呋塞米对APA患者的ARR影响不大,反而增加了不良反应的发生率。 Objective:To study the changes of plasma rennin activity(PRA),aldosterone(ALD) and aldosterone/rennin ratio(ARR) in response to posture test(single stimulation) and posture-furosemide test(double stimulation) in patients confirmed with aldsterone-producing adenoma(APA).Methods:Retrospective chart review was conducted on 112 APA patients who were confirmed by surgery and postoperative biopsy.Posture tests were performed on 60 patients,and posture-furosemide tests were conducted on 52 patients before surgery.Clinical characteristics,PRA,ALD,and ARR were compared.Results:No significant differences were observed between the two groups in clinical characteristics,PRA,ALD or ARR,whereas the frequency of side-effect related to the tests was higher in the double-stimulation group.Conclusion:The difference was not obvious whether or not furosemide was added in the posture test to evaluate APA,it might increase side-effects instead.
出处 《新医学》 2010年第12期780-782,共3页 Journal of New Medicine
关键词 醛固酮瘤 醛固酮/肾素比值 激发试验 Aldsterone-producing adenoma Aldosterone/rennin ratio Stimulation test
  • 相关文献

参考文献8

  • 1KIM R M,LEE J,SOH E Y.Predictors of resolution of hypertension after adrenalectomy in patients with aldosterone-producing adenoma[J].J Korean Med Sci,2010,25 (7):1041-1044.
  • 2MULATERO P,STOWASSER M,LOH K C,et al.Increased diagnosis of primary aldosteronism,including surgically correctable forms,in centers from five continents[J].J Clin Endocrinol Metab,2004,89 (3):1045-1050.
  • 3BERNINI G,MORETTI A,ORLANDINI C,et al.Plasma and urine aldosterone to plasma renin activity ratio in the diagnosis of primary aldosteronism[J].J Hypertens,2008,26 (5):981-988.
  • 4RITZ E,KOLEGANOVA N.Aldosterone in uremia-beyond blood pressure[J].Blood Purif,2010,29 (2):111-113.
  • 5李斌儒,朱秀莉,张勇.醛固酮对心血管疾病的影响与醛固酮受体阻断药的临床应用[J].新医学,2006,37(8):541-542. 被引量:3
  • 6曾正陪.内分泌性高血压的现状及诊治[J].临床内科杂志,2006,23(3):149-152. 被引量:18
  • 7黄启亚,肖辉盛,张少玲.原发性醛固酮增多症117例临床分析[J].新医学,2010,41(2):113-115. 被引量:5
  • 8GIACCHETTI G,RONCONI V,LUCARELLI G,et al.Analysis of screening and confirmatory tests in the diagnosis of primary aldosteronism:need for a standardized protocol[J].J Hypertens,2006,24 (4):737-745.

二级参考文献15

  • 1杨曙晖,严励,蔡梦茵,黎锋.原发性醛固酮增多症的诊治——附56例报告[J].新医学,2004,35(12):731-732. 被引量:2
  • 2翟绍忠,白悦心,孙良阁,赵高贤.原发性醛固酮增多症134例临床分析[J].河南肿瘤学杂志,2005,18(4):270-271. 被引量:6
  • 3吴木潮,程桦.血浆醛固酮/肾素活性比值——一个敏感的原发性醛固酮增多症的筛查指标[J].中华内分泌代谢杂志,2006,22(5):498-500. 被引量:10
  • 4张炜,罗邦尧.原发性醛固酮增多症[J].国际内分泌代谢杂志,2006,26(6):431-433. 被引量:7
  • 5ENG P H, TAN K E, KHOO D H, et al. Aldosterone to renin ratios in the evaluation of primary aldosteronism [J]. Ann Acad Med Singapore, 1997, 26 (6) : 762- 766.
  • 6LIM P O, YOUNG W F, MACDONALD T M. A review of the medical treatment of primary aldosteronism [ J ]. J Hypertens, 2001, 19(3) :353-361.
  • 7SATOH M, NAKAMURA M, SAITOH H, et al. Aldosterone synthase(CYP11 B2) expression and myocardial fibrosis in the failing human heart[J].Clin Sci, 2002, 102 (4): 381-386.
  • 8杨迎春,李延辉.现代心血管药物与临床[M].北京:人民军医出版社,2004:155—160.
  • 9PITT B, REMME W. ZANNAD F. et al. Eplerenone, a selective aldosteone blocker, in patients with left ventricular dysfunction after myocardialin farction[J]. N Engl J Med, 2003, 348 (14): 1309-1321.
  • 10ZANNAD F. DOUSSET B, ALLA, F. Treatment of congestive heart failure interfering the aldosterone cardiac extracellular matrix relationship [ J ]. Hypertension, 2001, 38 (5): 1227-1232.

共引文献23

同被引文献10

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部